|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Texas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing TexasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Insys Therapeutics, Inc.
| | | Phone: | (602) 910-2617 | Year Established: | 1990 | Ticker: | INSY | Exchange: | NASDAQ | Main Contact: | Saeed Motahari, President & CEO | | Other Contacts: | Ahmed Elkashef, M.D, VP, Clinical Development Ariyapadi Krishnaraj, VP, Commercial B. Sanga Emmanuel, VP, Chief Compliance Officer Steve Sherman, Senior VP, Regulatory Affairs Venkat R. Goskonda, Senior VP, R&D Franc Del Fosse, General Counsel Andrew G. Long, CFO
| | Company Description | INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients’ quality of life. Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids, INSYS is developing a pipeline of products intending to address unmet medical needs and the clinical shortcomings of existing commercial products | |
|
|
|
|
|